Deng Yalin, Hayes Kaleen N, Zhao Yifan, Chachlani Preeti, Zullo Andrew R, Djibo Djeneba Audrey, McMahill-Walraven Cheryl N, Mor Vincent, Harris Daniel A
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI 02903, USA; Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI 02903, USA.
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI 02903, USA; Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI 02903, USA; Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI 02903, USA.
Vaccine. 2025 Jan 1;43(Pt 2):126501. doi: 10.1016/j.vaccine.2024.126501. Epub 2024 Nov 7.
Racial and ethnic disparities in COVID-19 vaccine access are well-documented; however, few studies have examined whether racial disparities are modified by other factors, including geographic location and area-level deprivation.
We conducted an observational study using the COVVAXAGE database. Medicare beneficiaries who received the COVID-19 vaccine primary series (two doses) between 01/01/2021 and 12/31/2021 were included. Racial differences in the time between doses was assessed by urbanicity using g-formula methods.
We identified 11,924,990 beneficiaries (mean age = 75.4; 60 % female; 80 % White). Most beneficiaries (97.1 %) received their second vaccine on time. Delayed second doses were more common among beneficiaries who were Black (RR = 1.30, 95 %CI = 1.28-1.31) and rural (RR = 1.27, 95 %CI = 1.25-1.29) relative to White and urban beneficiaries. Racial disparities in delayed vaccinations varied in magnitude by degree of urbanicity.
Most beneficiaries received their second COVID-19 vaccine on time. Racial disparities were observed and shown to vary by geographic area.
新冠疫苗接种方面的种族和族裔差异已有充分记录;然而,很少有研究考察种族差异是否会因其他因素而改变,包括地理位置和地区层面的贫困程度。
我们使用COVVAXAGE数据库进行了一项观察性研究。纳入了在2021年1月1日至2021年12月31日期间接种了新冠疫苗基础系列(两剂)的医疗保险受益人。使用g公式方法按城市化程度评估剂次间隔时间的种族差异。
我们确定了11,924,990名受益人(平均年龄 = 75.4岁;60%为女性;80%为白人)。大多数受益人(97.1%)按时接种了第二剂疫苗。与白人及城市受益人相比,黑人(相对风险 = 1.30,95%置信区间 = 1.28 - 1.31)和农村受益人(相对风险 = 1.27,95%置信区间 = 1.25 - 1.29)中延迟接种第二剂的情况更为常见。延迟接种的种族差异程度因城市化程度而异。
大多数受益人按时接种了第二剂新冠疫苗。观察到了种族差异,且显示其因地理区域而异。